Literature DB >> 36269700

Ocular findings, surgery details and outcomes in proliferative diabetic retinopathy patients with chronic kidney disease.

Jipeng Li1, Aman Chandra2,3, Lin Liu1, Lin Zhang4, Jun Xu1, Meng Zhao1.   

Abstract

PURPOSE: We investigated the influence of impaired renal function on fundus characteristics, pars-plana vitrectomy (PPV) details, and outcomes in patients with proliferative diabetic retinopathy (PDR).
DESIGN: A retrospective cohort study.
METHODS: We investigated a consecutive series of PDR patients who underwent PPV. The diabetic complications, previous photocoagulation, intravitreal injections before PPV, ocular findings during PPV, surgical details, short-term visual outcome and post-PPV complications were recorded and compared between patients with and without impaired renal function.
RESULTS: 149 patients had normal renal function (67.7%), and 71 (32.3%) patients had impaired renal function; 85.4% of patients were identified with chronic kidney disease (CKD) during the preoperative assessment. Impaired renal function was related to hypertension (3.40[1.58-7.29], p = 0.002), incomplete pan-retinal photocoagulation (PRP) (3.18[1.50-6.72], p = 0.002), severe fibrovascular membrane (8.19[3.43-19.54], p<0.001), and extensive retinal vascular closure (3.40[1.54-7.52], p = 0.002). There was a more frequent occurrence of severe intraoperative bleeding (56.3%, 32.2%, p = 0.001) and a higher percentage of intraocular subretinal fluid drainage (45.1%, 22.1%, p = 0.008) in patients with impaired renal function. The percentage of patients whose visual acuity (VA) increased was similar between the two groups (42.3%, 54.4%, p = 0.34).
CONCLUSIONS: In PDR patients, screening for CKD was required before PPV. PDR patients with impaired renal function tended to have more severe ischemic retinal conditions. Comparable PPV outcomes could be obtained in patients with and without impaired renal damage.

Entities:  

Year:  2022        PMID: 36269700      PMCID: PMC9586353          DOI: 10.1371/journal.pone.0273133

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.752


  45 in total

1.  Intravitreal Bevacizumab for the Treatment of Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy.

Authors:  Rupin N Parikh; Anastasia Traband; Anton M Kolomeyer; Brian L VanderBeek; Benjamin J Kim; Albert M Maguire; Alexander J Brucker
Journal:  Am J Ophthalmol       Date:  2017-01-24       Impact factor: 5.258

Review 2.  Diabetic retinopathy.

Authors:  Tien Y Wong; Chui Ming Gemmy Cheung; Michael Larsen; Sanjay Sharma; Rafael Simó
Journal:  Nat Rev Dis Primers       Date:  2016-03-17       Impact factor: 52.329

3.  Prevalence, awareness and treatment of chronic kidney disease among middle-aged and elderly: The China Health and Retirement Longitudinal Study.

Authors:  Shengfeng Wang; Ru Chen; Qing Liu; Zheng Shu; Siyan Zhan; Liming Li
Journal:  Nephrology (Carlton)       Date:  2015-07       Impact factor: 2.506

4.  Long-Term Survival Rates of Patients Undergoing Vitrectomy for Proliferative Diabetic Retinopathy.

Authors:  Philip J Banerjee; Rene Moya; Catey Bunce; David G Charteris; David Yorston; Louisa Wickham
Journal:  Ophthalmic Epidemiol       Date:  2016-03-08       Impact factor: 1.648

5.  Prevalence of chronic complications of type 2 diabetes mellitus in outpatients - a cross-sectional hospital based survey in urban China.

Authors:  Zhaolan Liu; Chaowei Fu; Weibing Wang; Biao Xu
Journal:  Health Qual Life Outcomes       Date:  2010-06-26       Impact factor: 3.186

6.  Angiofibrotic response to vascular endothelial growth factor inhibition in diabetic retinal detachment: report no. 1.

Authors:  Elliott H Sohn; Shikun He; Leo A Kim; Hani Salehi-Had; Michael Javaheri; Christine Spee; Laurie Dustin; David R Hinton; Dean Eliott
Journal:  Arch Ophthalmol       Date:  2012-09

7.  Combined Tractional and Rhegmatogenous Retinal Detachment in Proliferative Diabetic Retinopathy in the Anti-VEGF Era.

Authors:  Ya-Jui Hsu; Yi-Ting Hsieh; Po-Ting Yeh; Jehn-Yu Huang; Chung-May Yang
Journal:  J Ophthalmol       Date:  2014-06-25       Impact factor: 1.909

8.  Risk Factors of Neovascular Glaucoma After 25-gauge Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage: A Retrospective Multicenter Study.

Authors:  Kei Takayama; Hideaki Someya; Hiroshi Yokoyama; Yoshihiro Takamura; Masakazu Morioka; Seiji Sameshima; Tetsuo Ueda; Shigehiko Kitano; Maki Tashiro; Masahiko Sugimoto; Mineo Kondo; Taiji Sakamoto; Masaru Takeuchi
Journal:  Sci Rep       Date:  2019-10-16       Impact factor: 4.379

9.  Chronic Kidney Disease and Diabetic Retinopathy in Patients with Type 2 Diabetes.

Authors:  Antonio Rodríguez-Poncelas; Xavier Mundet-Tudurí; Sonia Miravet-Jiménez; Aina Casellas; Joan F Barrot-De la Puente; Josep Franch-Nadal; Gabriel Coll-de Tuero
Journal:  PLoS One       Date:  2016-02-17       Impact factor: 3.240

Review 10.  Prevalence, risk factors and burden of diabetic retinopathy in China: a systematic review and meta-analysis.

Authors:  Peige Song; Jinyue Yu; Kit Yee Chan; Evropi Theodoratou; Igor Rudan
Journal:  J Glob Health       Date:  2018-06       Impact factor: 4.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.